Why choose USP Medicine Supply Map?
USP Medicine Supply Map
As supply chains become increasingly global and complex, digital transformation is no longer optional. It’s essential. The USP Medicine Supply Map (MSM) is an innovative drug shortages intelligence platform powered by advanced AI technology and predictive analytics that is designed to simplify and optimize supply chain management. It delivers proactive insights to identify and tackle potential risks throughout the global medicine supply chain. The platform helps manufacturers, health systems, distributors and buyers, and policymakers to make data-driven decisions that prevent disruptions and build a more resilient medicine supply chain.
How the USP Medicine Supply Map Helps You:
- Identify vulnerable drugs — Anticipate potential shortages and ensure visibility in supply chain management
- Optimize inventory — Adjust stock based on real-time risk assessments
- Secure contracts — Ensure stability through strategic planning
- Unlock new opportunities — Capitalize on market shifts and forecast trends
Key features
- Supply chain mapping. End-to-end visibility with integrated, trusted data for planning and coordination
- AI-driven prediction. Forecasts drug shortages 4-12 months ahead
- Risk driver analysis. Identifies and quantifies risks, using current market conditions and historical data to inform insights
- Market share intelligence. Focused monitoring of high-risk drug categories most vulnerable to shortages
- Regulatory alerts. Emailed notifications and updates on FDA inspection & recalls, warning letters, import alerts, and other key shortage signals
- Customizable views. Tailor views, apply filters, generate need-based reports, and create multiple watchlists by specific product, region, or supplier.
- Interactive dashboard. Filter dashboards to visualize risk trends and resilience in real-time, with links to related authoritative sources
- Monthly reports. Access regularly updated, trusted data and detailed monthly reports
- Model transparency. Review reports with details on model accuracy, false positives, and false negatives for complete confidence
Related insights
The Hidden Chokepoints in America's Medicine Supply Chain
Gain insight into upstream supply chain vulnerabilities with this USP Medicine Supply Map report that reveals Key Starting Materials (KSMs) have a high dependency on single-country sourcing and considerable geographic concentration.
2024 Drug Shortages Report
Identify the top medicines at risk and uncover the drivers behind persistent supply challenges, including pricing pressures, manufacturing delays, and geographic concentration.
Who we serve
Health systems & Hospitals:
Gain early visibility into supply disruptions, offering more time for planning.
Manufacturers & 503Bs:
Get real-time data on potential risks that can impact demand and production.
GPOs & Distributors:
Manage drug shortage costs with continuity plans supported by real-time supply chain intelligence.
Government:
Inform policy and funding decisions to prevent drug shortages, improve resiliency, and strengthen national security.